Telomere length and variation in telomere biology genes in individuals with osteosarcoma

International Journal of Molecular Epidemiology and Genetics

Volumn 2, Issue 1, 2011, Pages 19-29

  Mirabello, Lisa ^a   Richards, Elliott G ^a   Duong, Linh M ^a,b   Yu, Kai ^a   Wang, Zhaoming ^c   Cawthon, Richard ^d   Berndt, Sonja I ^a   Burdett, Laurie ^c   Chowdhury, Salma ^c   Teshome, Kedest ^c   Douglass, Chester ^e   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Epidemiology; Osteosarcoma; Single nucleotide polymorphism; Telomere; Telomere length

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; OSTEOSARCOMA; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

EID: 79251540934     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Mirabello L, Troisi RJ, and Savage SA. Osteosar-coma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009; 115(7): 1531-1543.
2. Longhi A, Pasini A, Cicognani A, Baronio F, Pella-cani A, Baldini N, and Bacci G. Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 2005; 27(6): 314-318.
3. Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, and Hoover RN. Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 2006; 95(11): 1603-1607.
4. Operskalski EA, Preston-Martin S, Henderson BE, and Visscher BR. A case-control study of os-teosarcoma in young persons. Am J Epidemiol 1987; 126(1): 118-126.
5. Ruza E, Sotillo E, Sierrasesumaga L, Azcona C, and Patino-Garcia A. Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer. J Pedi-atr Hematol Oncol 2003; 25(10): 780-786.
6. Lindor NM, McMaster ML, Lindor CJ, and Greene MH. Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr 2008;(38): 1-93.
7. Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, and Chanock SJ. Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 2007; 16(8): 1667-1674.
8. Koshkina NV, Kleinerman ES, Li G, Zhao CC, Wei Q, and Sturgis EM. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. J Pediatr Hematol Oncol 2007; 29(12): 815-821.
9. Toffoli G, Biason P, Russo A, De Mattia E, Cec-chin E, Hattinger CM, Pasello M, Alberghini M, Ferrari C, Scotlandi K, Picci P, and Serra M. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosar-coma development and survival. Clin Cancer Res 2009; 15(10): 3550-3556.
10. Hu YS, Pan Y, Li WH, Zhang Y, Li J, and Ma BA. Association between TGFBR1*6A and osteosar-coma: a chinese case-control study. BMC Cancer 2010; 10: 169
11. Patio-Garcia A, Sotillo-Pieiro E, Modesto C, and Sierrases-Maga L. Analysis of the human tumour necrosis factor-alpha (TNFalpha) gene promoter polymorphisms in children with bone cancer. J Med Genet 2000; 37(10): 789-792.
12. Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, and Chanock SJ. Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer 2007; 49(1): 28-33.
13. Mathieu N, Pirzio L, Freulet-Marriere MA, Des-maze C, and Sabatier L. Telomeres and chromosomal instability. Cell Mol Life Sci 2004; 61(6): 641-656.
14. Broberg K, Bjork J, Paulsson K, Hoglund M, and Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005; 26(7): 1263-1271.
15. McGrath M, Wong JY, Michaud D, Hunter DJ, and De V, I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007; 16(4): 815-819.
16. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, and Spitz MR. Te-lomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003; 95(16): 1211-1218.
17. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, Gallaher JL, Reid BJ, and Rabinovitch PS. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007; 16(12): 2649-2655.
18. Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, Gu J, and Wu X. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for eso-phageal cancer. Cancer Prev Res (Phila Pa) 2009; 2(5): 459-465.
19. Liu X, Bao G, Huo T, Wang Z, He X, and Dong G. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci 2009; 100(7): 1300-1305.
20. Hou L, Savage SA, Blaser MJ, Perez-Perez G, Hoxha M, Dioni L, Pegoraro V, Dong LM, Zatonski W, Lissowska J, Chow WH, and Baccarelli A. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Bio-markers Prev 2009; 18(11): 3103-3109.
21. Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De V, I, Hayes RB, and Savage SA. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009; 8(4): 405-413.
22. Zee RY, Castonguay AJ, Barton NS, and Buring JE. Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case -control approach. Cancer Epidemiol Biomarkers Prev 2009; 18(8): 2280-2282.
23. Pampalona J, Soler D, Genesca A, and Tusell L. Whole chromosome loss is promoted by telomere dysfunction in primary cells. Genes Chromosomes Cancer 2010;
24. Sandberg AA and Bridge JA. Updates on the cyto-genetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 2003; 145(1): 1-30.
25. Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, Brinkschmidt C, van Valen F, Boecker W, Dock-horn-Dworniczak B, and Poremba C. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 2001; 20(29): 3835-3844.
26. Shay JW and Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33 (5): 787-791.
27. Savage SA, Stewart BJ, Liao JS, Helman LJ, and Chanock SJ. Telomere stability genes are not mutated in osteosarcoma cell lines. Cancer Genet Cytogenet 2005; 160(1): 79-81.
28. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, and Gohagan JK. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21(6 Suppl): 273S-309S.
29. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009; 37(3): e21
30. Mirabello L, Garcia-Closas M, Cawthon R, Lis-sowska J, Brinton LA, Peplonska B, Sherman ME, and Savage SA. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 2010; 21(1): 77-82.
31. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Caporaso N, Kraft P, and Chatterjee N. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009; 33(8): 700-709.
32. Gauderman WJ. and Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. 2006;
33. Barrett JC, Fry B, Maller J, and Daly MJ. Haploview: analysis and visualization of LD and hap-lotype maps. Bioinformatics 2005; 21(2): 263-265.
34. Hosgood HD, III, Cawthon R, He X, Chanock S, and Lan Q. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer 2009;
35. Mirabello L, Garcia-Closas M, Cawthon R, Lis-sowska J, Brinton LA, Peplonska B, Sherman ME, and Savage SA. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 2009;
36. Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, and Wu X. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 2007; 178(4 Pt 1): 1492-1496.
37. Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ, and De V, I. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 2009; 129(2): 415-421.
38. Lan Q, Cawthon R, Shen M, Weinstein SJ, Vir-tamo J, Lim U, Hosgood HD, III, Albanes D, and Rothman N. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lym-phoma. Clin Cancer Res 2009; 15(23): 7429-7433.
39. Gramatges MM, Telli ML, Balise R, and Ford JM. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 2010; 19(2): 605-613.
40. Svenson U, Nordfjall K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, and Roos G. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 2008; 68(10): 3618-3623.
41. De V, I, Prescott J, Wong JY, Kraft P, Hankinson SE, and Hunter DJ. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2009; 18(4): 1152-1156.
42. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, and Santella RM. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007; 67(11): 5538-5544.
43. Zheng YL, Ambrosone C, Byrne C, Davis W, Nes-line M, and McCann SE. Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat 2009;
44. Liu X, Bao G, Huo T, Wang Z, He X, and Dong G. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci 2009; 100(7): 1300-1305.
45. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, Gallaher JL, Reid BJ, and Rabinovitch PS. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007; 16(12): 2649-2655.
46. Bekaert S, De Meyer T, Rietzschel ER, De Buyz-ere ML, De Bacquer D, Langlois M, Segers P, Cooman L, Van Damme P, Cassiman P, Van Criekinge W, Verdonck P, De Backer GG, Gille-bert TC, and Van Oostveldt P. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007; 6(5): 639-647.
47. Nordfjall K, Eliasson M, Stegmayr B, Melander O, Nilsson P, and Roos G. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 2008; 16(12): 2682-2689.
48. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, and Inoue M. Estrogen activates telomerase. Cancer Res 1999; 59(23): 5917-5921.
49. Kimura A, Ohmichi M, Kawagoe J, Kyo S, Mabu-chi S, Takahashi T, Ohshima C, Arimoto-Ishida E, Nishio Y, Inoue M, Kurachi H, Tasaka K, and Murata Y. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 2004; 23(26): 4505-4515.
50. Aviv A. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med 2002; 80(11): 689-695.
51. Palm W and de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42: 301-334.
52. Savage SA, Stewart BJ, Liao JS, Helman LJ, and Chanock SJ. Telomere stability genes are not mutated in osteosarcoma cell lines. Cancer Genet Cytogenet 2005; 160(1): 79-81.
53. Codd V, Mangino M, van der HP, Braund PS, Kaiser M, Beveridge AJ, Rafelt S, Moore J, Nelson C, Soranzo N, Zhai G, Valdes AM, Blackburn H, Mateo L, I, de Boer RA, Goodall AH, Ouwe-hand W, van Veldhuisen DJ, van Gilst WH, Navis G, Burton PR, Tobin MD, Hall AS, Thompson JR, Spector T, and Samani NJ. Common variants near TERC are associated with mean telomere length. Nat Genet 2010; 42(3): 197-199.
54. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, McLaughlin J, Shepherd F, Montpetit A, Narod S, Krokan HE, Skorpen F, Elvestad MB, Vatten L, Njolstad I, Axelsson T, Chen C, Goodman G, Barnett M, Loomis MM, Lubinski J, Maty-jasik J, Lener M, Oszutowska D, Field J, Liloglou T, Xinarianos G, Cassidy A, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, Gonzalez CA, Ramon QJ, Martinez C, Navarro C, Ardanaz E, Larranaga N, Kham KT, Key T, Bueno-de-Mesquita HB, Peeters PH, Trichopoulou A, Linseisen J, Boeing H, Hallmans G, Overvad K, Tjonneland A, Kumle M, Riboli E, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Ma-tsuda F, Blanche H, Gut I, Heath S, Lathrop M, and Brennan P. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008; 40(12): 1404-1406.
55. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, La-Croix A, Li D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet WR, Berg CD, Boutron-Ruault MC, Buring JE, Bracci PM, Can-zian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Parikh H, Patel AV, Peeters PH, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu XO, Thomas G, Tjonneland A, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF, Jr., Hoover RN, Hartge P, and Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010; 42(3): 224-228.
56. Vasa-Nicotera M, Brouilette S, Mangino M, Thompson JR, Braund P, Clemitson JR, Mason A, Bodycote CL, Raleigh SM, Louis E, and Samani NJ. Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 2005; 76(1): 147-151.
57. Andrew T, Aviv A, Falchi M, Surdulescu GL, Gardner JP, Lu X, Kimura M, Kato BS, Valdes AM, and Spector TD. Mapping genetic Loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet 2006; 78(3): 480-486.
58. Mangino M, Richards JB, Soranzo N, Zhai G, Aviv A, Valdes AM, Samani NJ, Deloukas P, and Spec-tor TD. A genome-wide association study identifies a novel locus on chromosome 18q12.2 influencing white cell telomere length. J Med Genet 2009; 46(7): 451-454.
59. Mirabello L, Yu K, Kraft P, De V, I, Hunter DJ, Prescott J, Wong JY, Chatterjee N, Hayes RB, and Savage SA. The association of telomere length and genetic variation in telomere biology genesa. Hum Mutat 2010; 31(9): 1050-1058.